promis® adult short form v1.0 with pain interference 8a (prom-pi) (ProMIS Neurosciences)
90
Structured Review
ProMIS Neurosciences
promis® adult short form v1.0 with pain interference 8a (prom-pi)
Promis® Adult Short Form V1.0 With Pain Interference 8a (Prom Pi), supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/promis-pi+short+form/promis+depression+v1+0/pmc12075408-56-2-6
Average 90 stars, based on 1 article reviews
Promis® Adult Short Form V1.0 With Pain Interference 8a (Prom Pi), supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/promis-pi+short+form/promis+depression+v1+0/pmc12075408-56-2-6
Average 90 stars, based on 1 article reviews
promis® adult short form v1.0 with pain interference 8a (prom-pi) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Defining numerical cut points for mild, moderate, and severe pain in adult burn survivors: A northwest regional burn model system investigation Article Snippet: An average pain intensity VAS/NRS score (0–10) and customized Article Title: Responsiveness and Minimal Important Change of the PROMIS Pain Interference Item Bank in Patients Presented in Musculoskeletal Practice. Article Snippet: estimated in our study are comparable to most of those previously reported.2,6,13,26,49 In our study, the responsiveness results were similar for the full bank, the derived short form, and simulated CAT, which may indicate that the Article Title: The Effectiveness of Interventions for Improving Chronic Pain Symptoms Among People With Mental Illness: A Systematic Review. Article Snippet: Cooperman et al, (2021) Total sample n = 30 Mean (SD) age 50.4 (8.8) years Male n = 15 (50%); Female n = 15 (50%) Black/African-American n = 16 (53%); White n = 11 (37%) Hispanic n = 6 (20%) MORE+ TAU group (n = 15): Mean (SD) age 47.9 (8.7) years Male n = 7 (47%); Female n = 8 (53%) Black/African-American n = 7 (47%); White n = 7 (47%) Hispanic n = 3 (20%) TAU group (n = 15): Mean (SD) age 52.9 (8.4) years Male n = 8 (53%); Female n = 7 (47%) Black/African-American n = 9 (60%); White n = 4 (27%) Hispanic n = 3 (20%) MORE + TAU vs TAU 8 weekly sessions with each session last 2 h – The RAND SF-36 pain subscale – The PACS – The CES-D – The BAI Garland et al, (2019) Total sample n = 30 MORE group (n = 15): Mean (SD) age 47.9 (8.7) years Male n = 7 (47%); Female n = 8 (53%) White n = 7 (47%); Black/AfricanAmerican n = 7 (47%) Hispanic n = 3 (20%); Other n = 1 (7%) TAU group (n = 15): Mean (SD) age 52.9 (8.4) years Male n = 8 (53%); Female n = 7 (47%) White n = 4 (27%); Black/AfricanAmerican n = 9 (60%) Hispanic n = 3 (20%) MORE vs TAU 8 weekly sessions with each last 2 h – A NRS for pain intensity – An NRS – Event-contingent ratings of opioid craving – Capacity to selfregulate opioid craving with an NRS Vowles et al, (2020) Total sample n = 35 Mean (SD) age 50.5 (10.5) years Male n = 30 (86%); Female n = 5 (14%) Non-Hispanic White n = 18 (51%); Latinx n = 10 (29%); Native American n = 6 (17%); Other n = 1 (3%) Integrated intervention group (n = 17): Mean (SD) age 48.3 (11.6) years UC group (n = 18): Mean (SD) age 53.3 (8.6) years No separate reporting on gender and ethnicity/race for intervention and control groups ACT + MBRP + UC vs UC 12 weekly sessions with each session last 90 min – The Article Title: Examining patient reported outcome measures for phantom limb pain: measurement use in a sample of Veterans with amputation. Article Snippet: Purpose: Phantom limb pain (PLP) is treated with medications and non-drug treatments.. Best clinical practices for measuring treatment outcomes have not been defined.. The objective of this study was to evaluate the internal consistency of patient-reported outcomes measures (PROMs) in a sample of Veterans with lower limb amputation. Article Title: Association of CTRP13 With Liver Enzymes and Cognitive Symptoms in Nonalcoholic Fatty Liver Disease Article Snippet: Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease in which patients present with metabolic dysregulation and obesity as well as fat accumulation in the liver.. Those with NAFLD frequently have symptoms of fatigue, sleep disturbance, depression, and cognitive dysfunction.. C1q/TNF-related protein 13 (CTRP13) regulates glucose metabolism and obesity in mice, yet the role of CTRP13 in human NAFLD has not been elucidated. Article Title: Comparing Perceived Pain Impact Between Younger and Older Adults With High Impact Chronic Pain: A Cross-Sectional Qualitative and Quantitative Survey Article Snippet: The Article Title: Musculoskeletal pain among medical residents: role of workplace safety climate and sexual harassment Article Snippet: Patient reported |